FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza
The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
What's Your Reaction?
.gif)